EGLN3 Peptide | 45-520P

EGLN3 Peptide | 45-520P | Gentaur UK, US & Europe Distribution

Short Description: EGLN3 Peptide

Species: Human

Location: EGLN3 peptide corresponds to 12 amino acids of EGLN3.

Tested Application: Bl

Application: EGLN3 Peptide is used for blocking the activity of EGLN3 antibody (catalog number 45-520). The EGLN3 antibody ships at 0.5 mg/mL and the EGLN3 Peptide ships as a 100 ug pellet. When peptide is reconstituted in 200 uL water, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.

Physical State: Lyophilized

Buffer: EGLN3 peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 μL water, the concentration will be 0.5 mg/mL.

Concentration: N/A

Storage: Store at -20˚C. When reconstituted minimize freezing and thawing.

NCBI Official Symbol: EGLN3

Alternate Names: PHD3, HIFPH3, HIFP4H3, Egl nine homolog 3, HPH-1, HIF-PH3

NCBI Gene ID: 112399

User Note: N/A

NCBI Official Name: Egl-9 Family Hypoxia-Inducible Factor 3

Background: N/A

Disclaimer: This product is for research use only.